Search research articles
Contact Us
Filters
Showing results (501-510 of 529) with videos related to
Page
of 53
Sort By:
Blood Cancer Journal
|
April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Blood
|
August 10, 2010
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
Wen-Chien Chou, Huai-Hsuan Huang, Hsin-An Hou, et al.
Blood Research
|
December 26, 2025
Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes
Wan-Hsuan Lee, Chien-Chin Lin, Xavier Cheng-Hong Tsai, et al.
American Journal of Hematology
|
October 12, 2013
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
Chien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
American Journal of Hematology
|
October 16, 2013
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
Hsin-An Hou, Yuan-Yeh Kuo, Jih-Luh Tang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 30, 2025
Molecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World Analysis
Tai-Chung Tseng, Yu-Sung Chang, Xavier Cheng-Hong Tsai, et al.
Blood Cancer Journal
|
September 8, 2018
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
Feng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
American Journal of Hematology
|
March 2, 2023
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia
Min-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, et al.
Blood Cancer Journal
|
May 19, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations
Sao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
American Journal of Hematology
|
May 22, 2014
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
Yi-Tsung Yang, Hsin-An Hou, Chieh-Yu Liu, et al.
Page
of 53
Search research articles
Search
Showing results (501-510 of 529) with videos related to
Sort By:
Page
of 53
Blood Cancer Journal
|
April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms
Wan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Blood
|
August 10, 2010
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
Wen-Chien Chou, Huai-Hsuan Huang, Hsin-An Hou, et al.
Blood Research
|
December 26, 2025
Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes
Wan-Hsuan Lee, Chien-Chin Lin, Xavier Cheng-Hong Tsai, et al.
American Journal of Hematology
|
October 12, 2013
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
Chien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
American Journal of Hematology
|
October 16, 2013
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
Hsin-An Hou, Yuan-Yeh Kuo, Jih-Luh Tang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 30, 2025
Molecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World Analysis
Tai-Chung Tseng, Yu-Sung Chang, Xavier Cheng-Hong Tsai, et al.
Blood Cancer Journal
|
September 8, 2018
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
Feng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
American Journal of Hematology
|
March 2, 2023
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia
Min-Yen Lo, Xavier Cheng-Hong Tsai, Chien-Chin Lin, et al.
Blood Cancer Journal
|
May 19, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations
Sao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, et al.
American Journal of Hematology
|
May 22, 2014
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
Yi-Tsung Yang, Hsin-An Hou, Chieh-Yu Liu, et al.
Page
of 53